OrphanReachLogo_1000x500_RGBOrphanReachLogo_1000x500_RGBOrphanReachLogo_1000x500_RGBOrphanReachLogo_1000x500_RGB
  • HOME
  • ABOUT
    • Note from the CEO
    • History
    • Orphan Reach-Emmes Merger
    • Our Clients
    • Quality
    • Why Orphan Reach
  • SERVICES
    • Orphan Strategy
    • Natural History
    • Clinical Development
      • Project Management
      • Clinical Monitoring
      • Regulatory Affairs
      • Data Management & Biostatistics
      • Safety/Pharmacovigilance
      • Quality Assurance
      • Investigator Recruitment
    • COA Training
    • Patient Support
    • Registries
  • ORPHAN FOCUS
    • Clinical Development Delivery
    • Orphan Strategy
    • Patient Recruitment
    • Patient Retention
    • Pediatric Research
  • GLOBAL REACH
    • North America
    • South America
    • Europe
    • Russia, Ukraine & Baltic Countries
    • Asia Pacific
    • India
    • Middle East
    • Africa
  • COVID-19
  • CONTACT
    • CAREERS
  • RESOURCES
    • Rare Disease Center Insights
    • White Papers
    • Latest News
    • Charity Spotlight Series
✕

Thomas

  • Home
  • New Releases
  • Thomas
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Covid 19
  • Events
  • News
  • Orphan Drug Development
  • Orphan Drug Research
  • Orphan Drug Trials
  • Orphan Drugs
  • orphan reach
  • Outsourcing in Clinical Trials
  • Rare Disease
  • Rare disease community
  • Rare Disease Day
  • Uncategorized
  • All
  • #Best CRO
  • #orphan drugs
  • Award winning CRO
  • clinical research
  • clinical trials
  • Clinical Trials in UK
  • clinical trials in US
  • Corona virus
  • Corona virus research
  • Covid-19
  • COVID-19 research
  • CRO in Europe
  • CRO in India
  • CRO in USA
  • orphan drug research
  • orphan drugs
  • orphan reach
  • patient centric
  • rare disease
  • rare disease research
  • rare disease US
  • Special CRO
  • Vicore Pharma
  • All
  • skhawas@qed-clinical.com
  • Georgia Rose
  • Thomas
October 18, 2017

Applied Clinical Trials Magazine publishes Orphan Reach article about Natural History Studies

The Scrip Magazine has published Orphan Reach’s latest article about Natural History Studies in their October 2017 issue: http://www.appliedclinicaltrialsonline.com/researchers-conduct-nh-studies-rare-diseases-and-drug-development.  
Do you like it?0
Read more
February 28, 2018

Orphan Reach to attend Orphan Drugs and Rare Diseases Global Congress 2018 Europe

We will attend the Orphan Drugs and Rare Diseases Global Congress 2018 Europe which is held in London on 8-9 March. Meet our CEO who will […]
Do you like it?0
Read more
March 6, 2018

Orphan Reach to attend the World Orphan Drug Congress USA

We will attend the World Orphan Drug Congress 2018 USA which is held in Washington, DC on 26-27 April. Meet our CEO who will be happy to talk […]
Do you like it?0
Read more
September 5, 2018

Orphan Reach to attend the 8th Orphan Drugs & Rare Diseases 2018 conference in Boston

We will attend the 8th Orphan Drugs & Rare Diseases 2018 Americas East Coast which is held in Boston, MA on 25-26 September. Meet our CEO […]
Do you like it?1
Read more
Prev page
123456789101112
Next page

RSS Industry News

Latest News

  • Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research November 16, 2021
  • Emmes launches Orphan Reach™: Emmes’ Rare Disease Center November 3, 2021
  • Emmes is excited to be attending the World Orphan Drug Congress in the USA August 20, 2021
  • Orphan Reach confirms acquisition by Emmes, a US-based global, full-service CRO May 17, 2021

Quick Links

  • Emmes’ External Privacy Notice
  • Terms of Use
  • Privacy and Cookie Policy
  • Emmes – About us
  • CheckOrphan
  • European Medicines Agency
  • EURORDIS
  • Global Rare Diseases Patient Registry and Data Repository (GRDR)
  • NIH – Common Data Elements
  • NORD
  • Rare Disease UK
  • U.S. Food and Drug Administration
  • Sitemap

Headquarters

The Old School
Newport Road
Woughton Park
Milton Keynes MK6 3AP
United Kingdom
Phone: +44 (0)1908 251 480
Fax: +44 (0)1908 251 499
E-mail: info@orphan-reach.com

Global office locations

Follow Us





© 2022 Orphan Reach™- A Rare Disease CRO for Orphan Drugs. All Rights Reserved.

    Input this code: captcha


    There are some changes in the data protection law, so we wanted you to know that we've updated our Privacy Policy. Your trust is important to us, and we want to make sure you understand what these changes mean for you.

    Please visit our Privacy Policy page for more information about our Privacy and Cookie Policy.

    Close